Compare GSK Consumer with Dabur - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs DABUR - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DABUR 
   Change

With over 125 years of existence, Dabur India is the fourth largest FMCG company in India. The company has a distinct positioning on the traditional Ayurvedic healthcare system having presence in personal care, health care and food. Domestic consumer... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER DABUR GSK CONSUMER/
DABUR
 
P/E (TTM) x 39.1 62.2 63.0% View Chart
P/BV x 11.0 14.2 78.0% View Chart
Dividend Yield % 1.0 0.6 173.4%  

Financials

 GSK CONSUMER   DABUR
EQUITY SHARE DATA
    GSK CONSUMER
Mar-19
DABUR
Mar-20
GSK CONSUMER/
DABUR
5-Yr Chart
Click to enlarge
High Rs7,819525 1,488.6%   
Low Rs5,832357 1,633.1%   
Sales per share (Unadj.) Rs1,136.949.1 2,313.3%  
Earnings per share (Unadj.) Rs233.78.2 2,851.7%  
Cash flow per share (Unadj.) Rs248.19.4 2,627.4%  
Dividends per share (Unadj.) Rs105.003.00 3,500.0%  
Dividend yield (eoy) %1.50.7 226.2%  
Book value per share (Unadj.) Rs973.537.4 2,604.3%  
Shares outstanding (eoy) m42.061,767.06 2.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.09.0 66.9%   
Avg P/E ratio x29.253.8 54.2%  
P/CF ratio (eoy) x27.546.7 58.9%  
Price / Book Value ratio x7.011.8 59.4%  
Dividend payout %44.936.6 122.7%   
Avg Mkt Cap Rs m287,083779,627 36.8%   
No. of employees `0003.87.7 49.7%   
Total wages/salary Rs m6,4469,477 68.0%   
Avg. sales/employee Rs Th12,440.211,220.5 110.9%   
Avg. wages/employee Rs Th1,677.01,224.5 137.0%   
Avg. net profit/employee Rs Th2,556.71,870.7 136.7%   
INCOME DATA
Net Sales Rs m47,82086,846 55.1%  
Other income Rs m4,3263,053 141.7%   
Total revenues Rs m52,14689,899 58.0%   
Gross profit Rs m11,41017,923 63.7%  
Depreciation Rs m6062,205 27.5%   
Interest Rs m8495 1.6%   
Profit before tax Rs m15,12318,276 82.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-1,000 0.0%   
Tax Rs m5,2952,797 189.3%   
Profit after tax Rs m9,82814,479 67.9%  
Gross profit margin %23.920.6 115.6%  
Effective tax rate %35.015.3 228.8%   
Net profit margin %20.616.7 123.3%  
BALANCE SHEET DATA
Current assets Rs m52,67448,803 107.9%   
Current liabilities Rs m18,14024,639 73.6%   
Net working cap to sales %72.227.8 259.6%  
Current ratio x2.92.0 146.6%  
Inventory Days Days3658 61.3%  
Debtors Days Days2934 86.1%  
Net fixed assets Rs m4,79823,993 20.0%   
Share capital Rs m4211,767 23.8%   
"Free" reserves Rs m40,52764,290 63.0%   
Net worth Rs m40,94766,058 62.0%   
Long term debt Rs m01,629 0.0%   
Total assets Rs m60,68193,540 64.9%  
Interest coverage x1,939.837.9 5,119.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.9 84.9%   
Return on assets %16.216.0 101.3%  
Return on equity %24.021.9 109.5%  
Return on capital %37.026.3 140.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,1712,446 129.6%   
Fx outflow Rs m1,770862 205.3%   
Net fx Rs m1,4011,584 88.4%   
CASH FLOW
From Operations Rs m6,71116,136 41.6%  
From Investments Rs m-3,351-5,168 64.8%  
From Financial Activity Rs m-3,768-10,430 36.1%  
Net Cashflow Rs m-408540 -75.5%  

Share Holding

Indian Promoters % 0.0 68.6 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 5.6 14.3%  
FIIs % 12.0 19.2 62.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 6.5 227.7%  
Shareholders   26,457 123,555 21.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   KWALITY  KRBL  VST INDUSTRIES  UNITED BREWERIES  GUJARAT AMBUJA  

Compare GSK CONSUMER With:   COCA COLA (US)  NESTLE (Switz.)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  



Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Related Views on News

DABUR Announces Quarterly Results (2QFY21); Net Profit Up 19.8% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, DABUR has posted a net profit of Rs 5 bn (up 19.8% YoY). Sales on the other hand came in at Rs 25 bn (up 13.7% YoY). Read on for a complete analysis of DABUR's quarterly results.

DABUR 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of DABUR for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of DABUR. Also includes updates on the valuation of DABUR.

Burger King IPO: Should You Subscribe to This QSR Chain Business? (IPO)

Dec 2, 2020

Does the company with one of the fastest-growing QSR chains in India have sound prospects?

DABUR Announces Quarterly Results (1QFY21); Net Profit Down 6.1% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, DABUR has posted a net profit of Rs 3 bn (down 6.1% YoY). Sales on the other hand came in at Rs 20 bn (down 12.9% YoY). Read on for a complete analysis of DABUR's quarterly results.

DABUR Announces Quarterly Results (4QFY20); Net Profit Down 24.1% (Quarterly Result Update)

May 29, 2020 | Updated on May 29, 2020

For the quarter ended March 2020, DABUR has posted a net profit of Rs 3 bn (down 24.1% YoY). Sales on the other hand came in at Rs 19 bn (down 12.3% YoY). Read on for a complete analysis of DABUR's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 15, 2020 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS